Who Owns Braveheart Bio Stock?
NASDAQ: BRVEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 35.55%
- Held by insiders
- 58.52%
- Institutional holders
- 38
- Institutions 35.5%
- Insiders 58.5%
- Public and other 5.9%
Who owns Braveheart Bio stock?
Institutional investors own about 35.5% of Braveheart Bio's shares, spread across 38 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 58.52% of BRVE.
The largest institutional holders are FMR, LLC (8.44%), Capital International Investors (1.45%) and Capital Research Global Investors (1.15%). Together, the top 10 institutions control 15.7% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their BRVE positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BRVE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| FMR, LLC | 7.59M | 8.44% | +100.0% |
| Capital International Investors | 1.30M | 1.45% | +100.0% |
| Capital Research Global Investors | 1.03M | 1.15% | +100.0% |
| Blackrock Inc. | 1.01M | 1.12% | +100.0% |
| Vanguard Capital Management LLC | 992.74K | 1.10% | +100.0% |
| Eventide Asset Management LLC | 910.00K | 1.01% | +100.0% |
| Massachusetts Financial Services Co. | 465.25K | 0.52% | +100.0% |
| Pivotal bioVenture Partners Investment Advisor, LLC | 317.35K | 0.35% | +100.0% |
| Geode Capital Management, LLC | 288.80K | 0.32% | +100.0% |
| UBS Group AG | 229.07K | 0.25% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BRVE
| Fund | Shares | % Held |
|---|---|---|
| SmallCap World Fund Inc | 2.27M | 2.53% |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.04M | 1.15% |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 779.60K | 0.87% |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 718.20K | 0.80% |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 559.56K | 0.62% |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 500.00K | 0.56% |
| Fidelity Securities Fund-Fidelity Small Cap Growth Fund | 465.40K | 0.52% |
| Fidelity Advisor Series VII-Fidelity Advisor Biotechnology Fund | 349.63K | 0.39% |
| MFS SERIES TRUST I-MFS New Discovery Fund | 345.98K | 0.38% |
| Fidelity Securities Fund-Fidelity Small Cap Growth K6 Fund | 243.36K | 0.27% |
Frequently asked questions
Who is the largest shareholder of Braveheart Bio?
FMR, LLC is the largest institutional shareholder of BRVE, owning 8.44% of shares outstanding (7.59M shares) as of its latest 13F filing.
What percentage of Braveheart Bio is owned by institutions?
Institutions own about 35.5% of BRVE shares and 85.7% of the public float.
How much of Braveheart Bio do insiders own?
Insiders, such as officers and directors, own about 58.52% of BRVE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.